These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 7788957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP, Boulad F, Small TN, Kernan NA, Reyes B, Childs BH, Brochstein JA, Laver J, Castro-Malaspina H, O'Reilly RJ.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM.
    Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502
    [Abstract] [Full Text] [Related]

  • 11. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bunin N, Aplenc R, Iannone R, Leahey A, Grupp S, Monos D, Pierson G.
    Bone Marrow Transplant; 2005 Feb 17; 35(4):369-73. PubMed ID: 15640818
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ, Hwang WS, Huang SH, Chao TY, Chang JY, Wang CC.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr 17; 57(4):247-53. PubMed ID: 8705875
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N, Zabelina T, Renges H, Krüger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander AR.
    Ann Hematol; 2002 Nov 17; 81(11):627-31. PubMed ID: 12454700
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 17; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 15. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A, Ortega Aramburu JJ, Bureo Dacal E, Badell Serra I, Madero López L, Olive Oliveras T, Cubells Riero J, Maldonado Regalado MS, Ramírez Orellana M.
    An Esp Pediatr; 1999 Jan 17; 50(1):29-32. PubMed ID: 10083639
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec 17; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 17. BMT for severe aplastic anemia using cyclosporine.
    May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB.
    Bone Marrow Transplant; 1993 Jun 17; 11(6):459-64. PubMed ID: 8334426
    [Abstract] [Full Text] [Related]

  • 18. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH, Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh RK.
    Bone Marrow Transplant; 1996 Aug 17; 18(2):273-7. PubMed ID: 8864434
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan 17; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 20. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb 17; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.